Login / Signup

Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies.

Sara PisaniKatie McGoohanLatha VelayudhanSagnik Bhattacharyya
Published in: Drugs & aging (2021)
Although cannabinoid-based medications were generally safe and acceptable to adults aged over 50 years, these estimates are limited by the lack of a control condition and considerable heterogeneity. Nevertheless, they complement and are consistent with comparable evidence from randomised controlled trials.
Keyphrases
  • open label
  • phase ii
  • clinical trial
  • phase iii
  • phase ii study
  • physical activity
  • single cell
  • study protocol
  • randomized controlled trial
  • squamous cell carcinoma
  • radiation therapy
  • rectal cancer